ADAR and neoplasm: Based on the functional induction of a type I interferon response by ADAR KO and the known downstream cascading immunological responses that can result from type I interferon, it is reasonable to hypothesize that engagement of even a relatively small fraction of cells within the tumor microenvironment would be sufficient to remodel the tumor microenvironment and enhance anti-tumor immunity.